PresseBox
Pressemitteilung BoxID: 778956 (Hocoma AG)
  • Hocoma AG
  • Industriestrasse 4
  • 8604 Volketswil
  • http://www.hocoma.com
  • Ansprechpartner
  • Mike Fuhrmann
  • +41 (43) 4442200

Andago walks away with an IF Design Award

We are proud to announce that another invention of our great team of engineers and creatives has been awarded the IF Design Award 2016

(PresseBox) (Volketswil, ) We continuously strive for perfection and excellence and satisfied therapists and happy patients are by far our greatest awards, but we always feel honored when our work is recognized by a group of experts such as the IF Design Award jury members.

IF International Forum Design GmbH is one of the oldest truly independent design institutions in the world and has been around since 1953 to identify, support and promote good design, to raise awareness of design among the public and to effect social change through design. This is the mission of the annual design competition, IF Design Award.

“We are thrilled we won this award for our latest innovation Andago”, so Mike Fuhrmann, CCO of Hocoma. “An award like this is a wonderful opportunity to announce that Andago is now on its way to training floors in modern rehabilitation centers around the world. It’s amazing how many requests we are receiving since we presented our prototype on a handful selected events in 2015.”

As Hocoma is known for innovative products and pathed the way for effective gait therapy and an entire new industry with its Lokomat over a decade ago, the Andago robot will bring modern and safe gait training to an entire new and mobile level.

Worldwide, US-based MossRehab was the first rehabilitation facility to pilot therapy with the Andago.

“It’s guided by your own walking,” Alberto Esquenazi, MD, MossRehab's chief medical officer explains. “The Andago will enable patients who’ve had a stroke or a traumatic brain injury to move more quickly from supported or assisted gait to unsupported walking”, Dr. Esquenazi says.

To learn more about Andago, please visit: www.hocoma.com/andago.

Product Disclaimer

All Hocoma products are medical devices and must be used in strict adherence to the User Manual; failure to do so may result in serious personal injury. It is strongly recommended that you regularly consult Hocoma’s website (www.hocoma.com/legalnotes) for the latest available information. Please contact Hocoma in case of any questions.

Use only under the supervision of qualified medical personnel. However, certain Hocoma products are marketed for home use and must be strictly used according to the recommendations of your medical care provider who is knowledgeable about your specific needs. Consult the User Manual and Hocoma’s website (www.hocoma.com/legalnotes) for appropriate product designation. Failure to obtain and follow the recommendations of your medical care provider may result in serious personal injury.

This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.

Website Promotion

Hocoma AG

A successful therapy begins in patients’ heads. In the firm belief that – step by step – they can reach their goals and regain quality of life.

This is what we work for at the Swiss medtech company Hocoma. With technologies and ideas that look at functional movement therapy from a completely different angle. Because they enable independent exercises and create maximum motivation. Because they challenge people to take courage and support their hopes with personal achievements.

We are committed to creating the ideal therapy. Our awarded robotic and sensor-based devices offer solutions for intensive gait therapy (Lokomat®, Andago®), functional therapy of the upper extremities (Armeo®), robotic mobilization and functional electrical stimulation in early rehabilitation (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo® Therapy Concept) at home and at the clinic. They are the result of intensive research, consistent development and continuous exchange with patients, therapists and partners in research and science.

Those who see to break new grounds need to stay open to exceptional ideas. They have the potential of being exceptionally effective. This guiding principle by Hocoma founder and CEO Dr. Gery Colombo has accompanied us since our start in 2000 and is still lived and implemented by our dedicated employees around the world. At the headquarters in Volketswil near Zurich (Switzerland) and the subsidiaries in the USA, Singapore and Slovenia they achieved a turnover of more than 30 million CHF in 2014.